Abstract
It is still uncertain how the epidemic characteristics of COVID-19 in its early phase and subsequent waves contributed to the pre-delta epidemic size in the United States. We identified the early and subsequent characteristics of the COVID-19 epidemic and the correlation between these characteristics and the pre-delta epidemic size. Most (96.1% (49/51)) of the states entered a fast-growing phase before the accumulative number of cases reached (30). The days required for the number of confirmed cases to increase from 30 to 100 was 5.6 (5.1–6.1) days. As of 31 March 2021, all 51 states experienced at least 2 waves of COVID-19 outbreaks, 23.5% (12/51) experienced 3 waves, and 15.7% (8/51) experienced 4 waves, the epidemic size of COVID-19 was 19,275–3,669,048 cases across the states. The pre-delta epidemic size was significantly correlated with the duration from 30 to 100 cases (p = 0.003, r = −0.405), the growth rate of the fast-growing phase (p = 0.012, r = 0.351), and the peak cases in the subsequent waves (K1 (p < 0.001, r = 0.794), K2 (p < 0.001, r = 0.595), K3 (p < 0.001, r = 0.977), and K4 (p = 0.002, r = 0.905)). We observed that both early and subsequent epidemic characteristics contribute to the pre-delta epidemic size of COVID-19. This identification is important to the prediction of the emerging viral infectious diseases in the primary stage.
Funder
Bill and Melinda Gates Foundation
National Natural Science Foundation of China
Outstanding Young Scholars Funding
China Postdoctoral Science Foundation
Fundamental Research Funds for the Central Universities
Natural Science Basic Research Program of Shaanxi Province
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference50 articles.
1. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
2. Coronavirus Resource Center of Johns Hopkins University & Medicine
https://coronavirus.jhu.edu/
3. Coronavirus in the U.S.: Latest Map and Case Count
https://www.nytimes.com/interactive/2021/us/covid-cases.html
4. First Case of 2019 Novel Coronavirus in the United States